tirzepatide cardiovascular outcome trial Effects of on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity Selected Efficacy and Outcome Findings
Description
Weeks 9 through 12 at 8mg typically produces the most dramatic changes
It is marketed by Eli Lilly and Company
If one medication is not producing adequate results, switching to another is preferable to stacking them
Preventing Toxicity: Taking doses too close together can lead to an excessively high concentration of the medication in your bloodstream
